All part of the cost cutting measures mate. They weren’t pushing the marketing side as hard in order to contain costs, now that costs are down and they have more scale with FDA approval the marketing side will pick up and so will sales.
- Forums
- ASX - By Stock
- The re-rate journey
LDX
lumos diagnostics holdings limited
Add to My Watchlist
0.00%
!
2.7¢

All part of the cost cutting measures mate. They weren’t pushing...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.21M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.6¢ | $24.66K | 945.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 315442 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 1463859 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 315442 | 0.026 |
10 | 1316132 | 0.025 |
1 | 1238229 | 0.024 |
1 | 40000 | 0.023 |
2 | 523000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 1463859 | 3 |
0.028 | 190000 | 1 |
0.029 | 77542 | 2 |
0.030 | 221800 | 1 |
0.031 | 309 | 1 |
Last trade - 15.59pm 24/06/2025 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |